Status:
TERMINATED
Efficacy of Extended-release, Once Daily Tramadol for Post Operative Analgesia in Shoulder Arthroscopy
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Pain
Vertigo
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The investigators hypothesize that the use of tramadol will reduce pain and analgesic consumption after arthroscopic shoulder surgery.
Detailed Description
The purpose of the study was to evaluate the efficacy of tramadol long acting for post operative pain in patients who had an arthroscopic shoulder surgery in ambulatory setting in comparison with a pl...
Eligibility Criteria
Inclusion
- aged more than 18 year old
- arthroscopic shoulder surgery on interscalen block
- able to understand the protocol
- inform consent signed
Exclusion
- chronic pain or chronic used of narcotics
- Use of IMAO
- Use of ISRS
- Pulmonary chronic disease
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02247648
Start Date
June 1 2013
End Date
December 1 2017
Last Update
July 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de chirurgie spécialisée de Montréal
Montreal, Quebec, Canada, h3s 2w1